Turk Ilac ve Serum Sanayi AS (TRILC) — Capital Reinvestment Ratio
Turk Ilac ve Serum Sanayi AS (TRILC) has a Capital Reinvestment Ratio of 3.20x as of September 2025, meaning it reinvests 3% of its operating cash flow (TL44.50 Million) in capital expenditures (TL142.42 Million). See TRILC net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Turk Ilac ve Serum Sanayi AS Capital Reinvestment Ratio (2019–2023)
This chart tracks Turk Ilac ve Serum Sanayi AS's Capital Reinvestment Ratio across 3 annual periods. Check TRILC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Turk Ilac ve Serum Sanayi AS (2019–2023)
Year-by-year Capital Reinvestment Ratio for Turk Ilac ve Serum Sanayi AS from 2019 to 2023. For live market cap and broader valuation context, see Turk Ilac ve Serum Sanayi AS stock valuation.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.28x | TL408.19 Million | TL115.31 Million | ▼ -43.3% |
| 2020 | 0.50x | TL33.20 Million | TL16.54 Million | ▼ -73.4% |
| 2019 | 1.87x | TL13.32 Million | TL24.92 Million | — |